Trends in HIV prevalence and incidence sex ratios in ALPHA demographic surveillance sites,
|
|
- Emerald Hunt
- 6 years ago
- Views:
Transcription
1 Trends in HIV prevalence and incidence sex ratios in ALPHA demographic surveillance sites, Zaba B 1, Calvert C 1, Marston M 1, Isingo R 2, Nakiyingi Miiro J 3, Lutalo T 4, Crampin A 1,5, Nyamukapa C 6, 7, Todd J 1, Reniers G 1 1 London School of Hygiene and Tropical Medicine, United Kingdom 2 National Institute for Medical Research, Tanzania 3 MRC/UVRI Uganda Research Unit on AIDS, Uganda 4 Rakai Health Sciences Program, Uganda 5 Karonga Prevention Study, Malawi 6 Imperial College, United Kingdom 7 Biomedical Research and Training Institute, Zimbabwe Short abstract Antiretroviral Therapy (ART) has two well described beneficial effects. First, it drastically prolongs the life expectancy of those receiving treatment, and second, it reduces HIV transmission to uninfected partners. The expansion of ART programs is thus expected to elevate HIV prevalence rates and reduce HIV incidence at the same time. These expectations are largely confirmed in a pooled dataset of five African demographic surveillance sites with HIV status information. Further, we find that the F/M sex ratio of prevalent infections increases over time and that suggests that ART coverage is better among women than men. This is corroborated by an increasing F/M sex ratio of incidence, suggesting that although the pool of HIV infected women is increased, less are infectious compared to the pool of HIV positive men. Our results thus indicate that higher ART coverage rates benefit HIV positive women (more than men) in term of increased survival, but benefit HIV negative men (more than women) because of a greater reduction in new infections.
2 Extended abstract Background and research questions Antiretroviral Therapy (ART) has two well described beneficial effects. First, it drastically prolongs the life expectancy of those receiving treatment [1], and second, it reduces HIV transmission to uninfected partners [2 3]. The expansion of ART programs is thus expected to inflate HIV prevalence rates and reduce HIV incidence at the same time. We explore gender differences in these epidemic markers because a number of studies have suggested that women make greater use of AIDS care services than men (and often at an earlier stage of disease progression) [4 5]. One study suggested that gender differences in the uptake of ART have become more explicit ever since antriretrovirals have been made available free of charge to the end user [6]. If ART coverage is indeed higher for HIV positive women compared to men, then the sex ratio of prevalent as well as incident infections should increase with the expansion of ART programs. Data and methods We seek evidence for these hypotheses in a pooled dataset of five demographic surveillance sites with HIV status information (Table 1). 1 These projects are located in East and Southern Africa and revolve around a regular census of the population under surveillance and community based testing for HIV. The population in these sites ranges from 7,000 32,000. Table 1: ALPHA demographic surveillance site attributes Study site Karonga Kisesa Manicaland Masaka Rakai Country Malawi Tanzania Zimbabwe Uganda Uganda Demographic surveillance HIV surveillance Other linked HIV testing 1982, ART roll-out in community * Population size (2008) 32,000 28,000 30,000 7,000 30, HIV prevalence 7% 7% 16% 6% 11% Total PYO (ages 15+) 147, ,000 57, , ,000 Age eligibility for testing ** (15-44 pre- 1999) Women:15 49 Men: (15 49 in some rounds) Notes: * ART rollout is still incomplete in Zimbabwe ** These age-eligibility criteria are not always strictly enforced 1 All of these sites are member of the ALPHA Network:
3 Because HIV surveys are not conducted on an annual basis and not everyone is tested in each survey round, we developed a set of rules for imputing missing values in order to maximize the utilization of the available data. These imputation rules are detailed in Table 2. Table 2: Imputation rules for annual HIV status information HIV negative HIV positive HIV status unknown notes Before first neg test Between first and last neg. test Included Included After last negative test Included for X years Included after X years X = 5 years Eastern Africa X = 2 years Southern Africa Before first pos. test Between first and last pos. test Included for Y years included Included before Y years Y = 5 years Eastern Africa Y = 2 years Southern Africa After last pos. test included Between last neg and first pos test never had HIV test Share after random allocation of infection date if interval < Z years Included if interval > Z years Included Z = 4 years Classified ineligible in the Manicaland study Figure 1: Proportion with HIV status unknown by study site, sex and year (adults aged 15 and above) Proportion HIV status unknown by sex and calendar year Karonga Kisesa Manical propunk Masaka Rakai calendar year males females Graphs by study_name
4 After imputation, HIV status information is known for 60 to 85 percent of the adults (aged 15 and above), and these figures vary considerably by location, period and sex (Figure 1). For the Manicaland site, we do not (currently) have information on who has been approached for an HIV test and cannot produce this statistic. The proportion with unknown HIV status is generally higher for men than for women and that is consistent with other studies that have identified higher non participation rates in serosurveillance studies among men [7], and, more generally, lower coverage of HIV testing and counseling (HTC) [8]. Over time, the proportion with unknown HIV status tends to increase (the Karonga site is an exception in this regard. HIV status information availability is generally lower in old age (not shown), but that is largely due to the age eligibility criteria for HIV testing in these studies. In the dataset for studying HIV incidence, we only include individuals with at least one negative HIV test result, and the analysis intervals are bounded by the first and last test (no assumptions about prepositive or post negative status are required). We randomly distribute sero conversions between the date of the last negative and first positive test in order to avoid spurious incidence peaks between serosurveys. Sero conversion intervals in excess of 4 years are excluded because these would not allow us to attribute the sero conversions to the pre or post ART period. For studying gender differences in HIV prevalence over time, we use logistic regression to model the odds that an individual is HIV positive. We are particularly interested in an interaction effect between sex and dummies pertaining to the stage of ART availability in the community. We distinguish three phases: the pre ART phase, the rollout phase and the phase where ART is available to everyone. For modelling HIV incidence, we rely on a piece wise exponential regression model. Again, we are interested in an interaction effect between sex and the stage of ART availability. Preliminary results Figure 2: Trends in sex ratio of HIV prevalence by age group, pooled data 5 ALPHA sites HIV prevalence sex ratios by age group and calendar year HIV status data for all studies combined Prevalence sex ratio calendar year
5 (a) HIV prevalence We first present trends in the F/M sex ratio of HIV prevalence by age in all sites combined (Figure 2). This illustration highlights that the F/M prevalence ratio is particularly high in young adults, and that is a direct result of the younger age pattern of infections among women. More interesting for the current discussion is the fact that the sex ratio of prevalent infections slowly increases in the 2000s. That could indeed result from the fact that women have privileged access to or simply make better use of the available AIDS care services. These interpretations are confirmed in a (preliminary) multivariable analysis whereby we model HIV status (Table 3). The first model, without interactions, indicates that HIV prevalence is higher for women than for men, that it varies by age and by site, and also that it increased with the expansion of ART programs. The model with interactions adds that the F/M sex ratio of prevalence is significantly higher in the period that ART has been available (even after accounting for a year by year linear increase in the sex ratio of infections), and that could indeed indicate that HIV positive women survive longer because of higher ART utilization rates. Table 3: Logistic regression of HIV status on background characteristics (ALPHA sites, ) MODEL 1: NO INTERACTIONS MODEL 2: SEX INTERACTIONS Odds Ratio sig Odds Ratio sig Male (ref) 1 Male (ref) 1 fem 1.34 *** fem 1.65 *** Karonga 1.14 *** Karonga 1.13 *** Kisesa 0.76 *** Kisesa 0.76 *** Masaka (ref) 1 Masaka (ref) 1 Manical 3.01 *** Manical 3.07 *** Rakai 1.70 *** Rakai 1.68 *** sex interaction *** *** 1.98 *** *** *** 1.60 *** (ref) (ref) *** *** 0.83 *** *** *** 0.62 *** *** *** 0.48 *** *** 0.42 *** *** *** 0.39 *** *** ** 0.44 *** *** *** 0.28 *** none (ref) 1 none (ref) 1 1 roll out 0.98 roll out 0.95 * 1.06 * available 1.05 * available ** year (cont) 0.99 *** year (cont) 0.99 ** 1.00
6 (b) HIV incidence Figure 3: Age specific patterns of HIV incidence by ART availability, pooled data 3 ALPHA sites HIV infection hazard by age, sex and ART availability pooled data for Kisesa, Masaka and Rakai pre-art ART introduction ART available age age age male female male female male female Figure 4: Trends in sex ratio of crude HIV incidence rate, by study site sexratio_crude Trends in sex ratio (F/M) of crude incidence rate, by site calendar year Karonga Manical Rakai Kisesa Masaka
7 Figure 3 illustrates the decline in HIV incidence rates in recent years: whereas incidence rates in young adults were still around 1% in the pre ART period, the peak incidence is less than half a percent in recent years. ART probably contributes to the reduction in incidence rates, but it is unlikely to be the sole factor of importance. The age pattern of incidence rates becomes progressively older (especially for women), and there is increasing similarity in the age pattern of HIV incidence between men and women. Figure 4 suggests that the sex ratio of the crude incidence rate has generally increased over time, although Rakai and Karonga do not maintain this trend throughout. The differences in age pattern of incidence shown in figure 3, suggest the sex ratio will change at different rates in different age groups. Determinants of the sex ratio of new infections are further explored in the analysis presented in Table 4. This analysis shows us that the incidence rate declined over time, particularly after the expansion of the ART programs in the sites. However, that decline is much more pronounced for men compared to women (the interaction between sex and ART availability is positive and significant) and that has led to an increase in the F/M sex ration of new infections. Table 4: Piece wise exponential regression of incident HIV infections on background characteristics characteristics (ALPHA Network sites, ) MODEL 1: NO INTERACTIONS MODEL 2: WITH SEX INTERACTIONS Hazard Ratio sig Hazard Ratio sig Male (ref) 1 Male (ref) 1 fem 1.07 *** fem 0.99 Karonga 0.87 ** Karonga 0.84 *** Kisesa 1.56 *** Kisesa 1.57 *** Masaka (ref) 1 Masaka (ref) 1 Manical 2.17 *** Manical 2.17 *** Rakai 1.84 *** Rakai 1.82 *** sex interaction *** *** 1.92 *** * 1.19 *** (ref) (ref) *** * *** *** 0.78 *** *** *** 0.82 ** *** *** *** *** *** *** 0.63 ** *** *** 0.39 *** none (ref) 1 none (ref) 1 1 roll out 0.90 *** roll out 0.86 *** 1.08 * available 0.54 *** available 0.45 *** 1.34 ** year (cont) 0.96 *** year (cont) 0.95 *** 1.02 **
8 Concluding remarks The sex ratio of prevalent as well as incident infections increased in conjunction with the expansion of ART programs in these sites and that suggest that women have higher ART enrollment rates than men. We assert that higher ART coverage rates benefit HIV positive women (more than men) in term of increased survival, but benefit HIV negative men (more than women) because of a greater reduction in new infections. In the full paper we will extend the evidence presented here with more detailed statistical analysis and will complement our data with information on ART enrollment in the study sites. References 1. Life expectancy of individuals on combination antiretroviral therapy in high income countries: a collaborative analysis of 14 cohort studies. Lancet, (9635): p Cohen, M.S., et al., Prevention of HIV 1 infection with early antiretroviral therapy. N Engl J Med, (6): p Smith, K., et al., HIV 1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS, (4): p Muula, A.S., et al., Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health, : p Braitstein, P., et al., Gender and the use of antiretroviral treatment in resource constrained settings: findings from a multicenter collaboration. Journal of Women's Health, (1): p Reniers, G., et al., Steep declines in population level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS, (4): p Reniers, G. and J. Eaton, Refusal bias in HIV prevalence estimates from nationally representative seroprevalence surveys. AIDS, (5): p Venkatesh, K.K., et al., Who gets tested for HIV in a South African urban township? Implications for test and treat and gender based prevention interventions. Journal of Acquired Immune Deficiency Syndromes, (2): p
Downloaded from:
Floyd, S; Marston, M; Baisley, K; Wringe, A; Herbst, K; Chihana, M; Kasamba, I; Brnighausen, T; Urassa, M; French, N; Todd, J; Zaba, B (2012) The effect of antiretroviral therapy provision on all-cause,
More informationDownloaded from:
Tenu, F; Isingo, R; Zaba, B; Urassa, M; Todd, J (2014) Adjusting the HIV prevalence for non-respondents using mortality rates in an open cohort in northwest Tanzania. Tropical medicine & international
More informationRecent declines in HIV prevalence and incidence in Magu DSS,
Recent declines in HIV prevalence and incidence in Magu DSS, 1994-2007 Mark Urassa, Raphael Isingo, Milalu Ndege, Milly Marston, Julius Mngara, Basia Zaba and John Changalucha INDEPTH conference, Dar-es-Salaam,
More informationService coverage and mortality along the HIV care cascade in rural Uganda
Uganda Virus Research Institute Service coverage and mortality along the HIV care cascade in rural Uganda Ivan Kasamba Kyamulibwa, Uganda ISC, Addis Ababa, 10 November 2015 Background HIV/AIDS epidemic
More informationEstimating Incidence of HIV with Synthetic Cohorts and Varying Mortality in Uganda
Estimating Incidence of HIV with Synthetic Cohorts and Varying Mortality in Uganda Abstract We estimate the incidence of HIV using two cross-sectional surveys in Uganda with varying mortality rates. The
More informationDownloaded from:
Marston, M; Nakiyingi-Miiro, J; Kusemererwa, S; Urassa, M; Michael, D; Nyamukapa, C; Gregson, S; Zaba, B; Eaton, JW; ALPHA network, (2017) The effects of HIV on fertility by infection duration: evidence
More informationChange In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:
Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: 1986-2009 Rein Houben/Sebastian Mboma Karonga Prevention Study Incidence of SS+ TB (n/100,000/year
More informationHow HIV prevalence, number of sexual partners and marital status are related in rural Uganda.
How HIV prevalence, number of sexual partners and marital status are related in rural Uganda. Ivan Kasamba (2), Dermot Maher (2), Sam Biraro (2), Heiner Grosskurth (1,2), Jim Todd (1). 1. LSHTM, Keppel
More informationThe consequences of age-specific fertility rates and HIV subfertility on national HIV epidemic estimates from antenatal clinic prevalence
The consequences of age-specific fertility rates and HIV subfertility on national HIV epidemic estimates from antenatal clinic prevalence Jeffrey W Eaton 1, Milly Marston 2, on behalf of the ALPHA Network
More informationSustained 10-year gain in adult life expectancy following antiretroviral therapy roll-out in rural Malawi: July 2005 to June 2014
International Journal of Epidemiology, 2017, 479 491 doi: 10.1093/ije/dyw208 Advance Access Publication Date: 14 October 2016 Original article HIV Treatment Sustained 10-year gain in adult life expectancy
More informationEmpirical Validation of the UNAIDS Spectrum Model for Subnational HIV Estimates: Case-Study of Children and Adults in Manicaland, Zimbabwe
Empirical Validation of the UNAIDS Spectrum Model for Subnational HIV Estimates: Case-Study of Children and Adults in Manicaland, Zimbabwe Romain SILHOL 1, Simon GREGSON 1,2, Constance NYAMUKAPA 1,2, Mutsa
More informationIs ABC enough to explain changes in HIV prevalence in rural Uganda?
Is ABC enough to explain changes in HIV prevalence in rural Uganda? Jim Todd (1), Dermot Maher (2), Ivan Kasamba (2), Emma Slaymaker (1), Basia Zaba (1), Heiner Grosskurth (1,2). 1. LSHTM, Keppel Street,
More informationImproving UNAIDS paediatric and adolescent estimates
Improving UNAIDS paediatric and adolescent estimates BACKGROUND This document provides paediatric HIV programme managers with an overview of how paediatric and adolescent estimates are produced, what the
More informationQ&A on HIV/AIDS estimates
Q&A on HIV/AIDS estimates 07 Last updated: November 2007 Understanding the latest estimates of the 2007 AIDS Epidemic Update Part one: The data 1. What data do UNAIDS and WHO base their HIV prevalence
More informationThe declining HIV seroprevalence in Uganda: what evidence?
Health Transition Review, Supplement to Volume 5, 1995, 27-33 The declining HIV seroprevalence in Uganda: what evidence? Joseph K. Konde-Lule Institute of Public Health, Makerere University, Kampala Papers
More informationCombination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium
Combination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium Preventing HIV includes Create an enabling environment Reduce Exposure behavior
More informationHIV Viral Load Testing Market Analysis. September 2012 Laboratory Services Team Clinton Health Access Initiative
HIV Viral Load Testing Market Analysis September 2012 Laboratory Services Team Clinton Health Access Initiative Agenda Background on Viral Load Testing Growth of Global Viral Load Market Factors Impacting
More informationThe population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort
The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort Frank Tanser Presentation at the South African Clinicians Society Conference
More informationHIV Prevention. Recent Advances and Implications for the Caribbean
HIV Prevention Recent Advances and Implications for the Caribbean Chris Behrens, MD CCAS/CHART Conference Barbados, August 2010 Cases 200 180 160 140 120 100 80 60 40 20 0 Year HIV Cases AIDS Cases HIV
More informationA Comprehensive Review of Empirical and Modeled HIV Incidence Trends ( )
Policy Research Working Paper 7042 WPS7042 A Comprehensive Review of Empirical and Modeled HIV Incidence Trends (1990 2012) Jessica Taaffe Nicole Fraser-Hurt Marelize Gorgens Pandu Harimurti Public Disclosure
More informationThe population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort
The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort Frank Tanser Presentation at 8 th International Workshop on HIV Treatment,
More informationData Use to Inform HIV Programs and Policies. Usma Khan, MS Hilary Spindler, MPH Prevention and Public Health Group Global Health Sciences
Data Use to Inform HIV Programs and Policies Usma Khan, MS Hilary Spindler, MPH Prevention and Public Health Group Global Health Sciences Who We Are Prevention and Public Health Group of Global Health
More informationASSESSMENT OF EFFECTIVE COVERAGE OF HIV PREVENTION OF PREGNANT MOTHER TO CHILD TRANSIMISSION SERVICES IN JIMMA ZONE, SOUTH WEST ETHIOPIA
ORIGINAL ARTICLE Assessment of Effective Coverage of HIV Mohammed H. et al ASSESSMENT OF EFFECTIVE COVERAGE OF HIV PREVENTION OF PREGNANT MOTHER TO CHILD TRANSIMISSION SERVICES IN JIMMA ZONE, SOUTH WEST
More informationSex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in the Democratic Republic of Congo
Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in the Democratic Republic of Congo Tania Tchissambou ICAP at Columbia University March 16,
More informationCombination prevention: Public health and human rights imperatives
Combination prevention: Public health and human rights imperatives Gottfried Hirnschall, MD MPH HIV/AIDS Department WHO, Geneva London, June 11, 2012 Outline The epidemic and response What is combination
More informationEpidemiology of measles in infants younger than 6 months: analysis of surveillance data
Epidemiology of measles in infants younger than 6 months: analysis of surveillance data 2011-2016 An analysis of the epidemiology of measles in infants younger than 6 months was conducted by the U.S. CDC
More informationNumber of people receiving ARV therapy in developing and transitional countries by region,
Progress in numbers The last six months have seen dramatic progress toward the 3 by 5 target. Between June and, the number of people receiving antiretroviral (ARV) therapy in developing and transitional
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationRenewing Momentum in the fight against HIV/AIDS
2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly
More informationBone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda
Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda Flavia Matovu Kiweewa, Noah Kiwanuka, Delia Scholes, Esther Isingel, Mary Glenn Fowler, Clemensia
More informationLearning from the past: How prepared are we for future HIV vaccine efficacy trials in Uganda
Learning from the past: How prepared are we for future HIV vaccine efficacy trials in Uganda Pontiano Kaleebu MRC-UVRI Uganda Research Unit on AIDS & UVRI-IAVI HIV Vaccine Programme Past 1987 Cohort studies
More informationUGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA
EXTENDED SUMMARY SHEET: PRELIMINARY FINDINGS APRIL 018 UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA 016 017 The Uganda Population-based HIV Impact Assessment (UPHIA), a household-based national
More informationThe Effect of HIV/AIDS on Fertility: What Role Are Proximate Determinants Playing? J. Alice Nixon University of Maryland
The Effect of HIV/AIDS on Fertility: What Role Are Proximate Determinants Playing? J. Alice Nixon University of Maryland 1 The global fertility rate has dropped significantly over the past 50 years from
More informationART FOR ART PREVENTION. Introduction of ongoing or planned trials
ART FOR ART PREVENTION Introduction of ongoing or planned trials François Dabis, MD, PhD for WHO Department of HIV/AIDS Geneva - November 3, 2009 ART FOR ART PREVENTION as of November 2009 Descriptive
More informationCan we treat our way out of the HIV epidemic?
Can we treat our way out of the HIV epidemic? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University Schoolboy s (and politician s) tricks for evading the question
More informationWHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team
WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic
More informationYoung Women s Marital Status and HIV Risk in Sub-Saharan Africa: Evidence from Lesotho, Swaziland and Zimbabwe
Young Women s Marital Status and HIV Risk in Sub-Saharan Africa: Evidence from Lesotho, Swaziland and Zimbabwe Christobel Asiedu Department of Social Sciences, Louisiana Tech University; casiedu@latech.edu
More informationProgress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS
10 th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource-Limited setting (INTEREST, 3-6 May, 2016) Progress in scaling up HIV prevention and treatment in sub-saharan
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationHow has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH
How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationWhy Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV?
Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Epidemiology of HIV in Adolescent & Young Women Lynne M. Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation
More informationTrends in extra-partner sexual relationship and condom use in sub-saharan Africa
Trends in extra-partner sexual relationship and condom use in sub-saharan Africa Agbessi Amouzou 1 ; Stan Becker 2 1. Elizabeth Glaser Pediatric AIDS Foundation (aamouzou@pedaids.org) 2. John Hokpins University
More informationDownloaded from:
Gourlay, A; Wringe, A; Todd, J; Cawley, C; Michael, D; Machemba, R; Clark, B; Masesa, C; Marston, M; Urassa, M; Zaba, B (2016) Uptake of services for prevention of mother-to-child transmission of HIV in
More informationHIV Drug Resistance Regional Update Eastern & Southern African Region
HIV Drug Resistance Regional Update Eastern & Southern African Region Dr R Banda, IST/ESA Dr F Cham, IST/ESA Dr RG Vaz, WHO AFRO HIVDR Steering Committee Meeting, Geneva 11-12 November 2009 1 Presentation
More informationSupplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time.
Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time. Anne Cori* 1, Michael Pickles* 1, Ard van Sighem 2, Luuk Gras 2,
More informationECONOMIC AND SOCIAL RESEARCH COUNCIL END OF AWARD REPORT
ECONOMIC AND SOCIAL RESEARCH COUNCIL END OF AWARD REPT For awards ending on or after 1 November 2009 This End of Award Report should be completed and submitted using the grant reference as the email subject,
More informationFACTORS ASSOCIATED WITH CHOICE OF POST-ABORTION CONTRACEPTIVE IN ADDIS ABABA, ETHIOPIA. University of California, Berkeley, USA
FACTORS ASSOCIATED WITH CHOICE OF POST-ABORTION CONTRACEPTIVE IN ADDIS ABABA, ETHIOPIA Ndola Prata 1, Caitlin Gerdts 1, Martine Holston, Yilma Melkamu 1 Bixby Center for Population, Health, and Sustainability;
More informationTying it all together health economic modeling
Tying it all together health economic modeling Ruanne V Barnabas, MD, DPhil Associate Professor, Global Health, Allergy & Infectious Disease University of Washington How models can be used with cost-effectiveness
More informationTHE EFFECT OF VCT TESTING AND UPTAKE OF HIV/ART CARE ON MODERN CONTRACEPTIVE USE AMONG WOMEN IN RAKAI, UGANDA
THE EFFECT OF VCT TESTING AND UPTAKE OF HIV/ART CARE ON MODERN CONTRACEPTIVE USE AMONG WOMEN IN RAKAI, UGANDA Fredrick Makumbi; Gertrude Nakigozi; Tom Lutalo; Joseph Kagaayi; Joseph Sekasanvu; Absalom
More informationTuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
More informationTorin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015
Estimating the impact of identifying and treating HIV-infected male circumcision clients in Uganda, Zambia, and Swaziland: a mathematical modeling analysis Torin Schaafsma A thesis submitted in partial
More informationPrevalence of sexual intercourse among school-going adolescents in Coast Province, Kenya
Tanzania Health Research Bulletin (2007), Vol. 9, No. 3 159 Prevalence of sexual intercourse among school-going adolescents in Coast Province, Kenya E. RUDATSIKIRA 1, A.E.O. OGWELL 2, S. SIZIYA 3* and
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More information, ZabaB;, MarstonM;, FloydS (2004) The effect of HIV on Child Mortality Trends in sub-saharan Africa. UN Population Bulletin.
, ZabaB;, MarstonM;, FloydS (2004) The effect of HIV on Child Mortality Trends in sub-saharan Africa. N Population Bulletin. Downloaded from: http://researchonline.lshtm.ac.uk/15572/ DOI: sage Guidelines
More informationIn 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
More informationFertility of HIV-infected women: insights from Demographic and Health Surveys
Fertility of HIV-infected women: insights from Demographic and Health Surveys Wei-Ju Chen, Neff Walker < An additional supplemental file published online only. To view this file please visit the journal
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationHIV Vaccine Clinical Trials at CIDRZ
HIV Vaccine Clinical Trials at CIDRZ Developing a Safe and Effective Vaccine for Prevention of HIV Infections Globally Christine Namakobo Senior Research Nurse Matero Clinical Research Site State of Global
More informationSexual multipartnership and condom use among adolescent boys in four sub-saharan African countries
1 Sexual multipartnership and condom use among adolescent boys in four sub-saharan African countries Guiella Georges, Department of demography, University of Montreal Email: georges.guiella@umontreal.ca
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More informationHIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP
HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples
More informationincreased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
More informationKigali Province East Province North Province South Province West Province discordant couples
EXECUTIVE SUMMARY This report summarizes the processes, findings, and recommendations of the Rwanda Triangulation Project, 2008. Triangulation aims to synthesize data from multiple sources to strengthen
More informationEnding AIDS in Gabon: How long will it take? How much will it cost?
Ending AIDS in Gabon: How long will it take? How much will it cost? Brian G. Williams, Eleanor Gouws* and David Ginsburg South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch,
More informationHIV incidence time trend and characteristics of recent seroconverters in a rural community with high HIV prevalence: South Africa
HIV incidence time trend and characteristics of recent seroconverters in a rural community with high HIV prevalence: South Africa Till Bärnighausen 1, Oscar Bangre 2, Frank Tanser 1, Graham Cooke 3, Marie-Louise
More informationModule 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs
Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Module Time Learning Objectives To provide the participants with the basic concepts of
More informationMalawi s Option B+ Key Considerations & Progress
Malawi s Option B+ Key Considerations & Progress HIV in Malawi 16 million population 1.1 million HIV population 10% adult HIV prevalence High rural burden 26,000 AIDS deaths 63,000 HIV+ pregn. women 5.7
More informationHIV EPIDEMIOLOGY: A REVIEW OF RECENT TRENDS AND LESSONS. David Wilson Global HIV/AIDS Program The World Bank. First draft, 13th September 2006
HIV EPIDEMIOLOGY: A REVIEW OF RECENT TRENDS AND LESSONS David Wilson Global HIV/AIDS Program The World Bank First draft, 13th September 26 Introduction Our understanding of HIV epidemiology continues to
More informationFAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030
Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December
More informationHome testing and counselling with linkage to care. Becky L Genberg, Joseph W Hogan and Paula Braitstein
Home testing and counselling with linkage to care Becky L Genberg, Joseph W Hogan and Paula Braitstein Globally, researchers and programme implementers strive towards the ambitious UNAIDS goal of 90-90-90
More informationEPIDEMIOLOGY AND RISK FACTORS OF HIV INFECTION AMONG URBAN WOMEN IN TANZANIA: EVIDENCES FROM TANZANIA HIV/AIDS
7 th African Population Conference EPIDEMIOLOGY AND RISK FACTORS OF HIV INFECTION AMONG URBAN WOMEN IN TANZANIA: EVIDENCES FROM TANZANIA HIV/AIDS 2011-12 Rakesh Kumar Singh 1 ABSTRACT The present study
More informationSouth et al. BMC Public Health 2013, 13:802
South et al. BMC Public Health 2013, 13:802 RESEARCH ARTICLE Open Access Do accurate HIV and antiretroviral therapy knowledge, and previous testing experiences increase the uptake of HIV voluntary counselling
More informationResearch and Evaluation Agenda for Maternal Health and HIV In sub-saharan Africa
Research and Evaluation Agenda for Maternal Health and HIV In sub-saharan Africa Tamil Kendall Isabella Danel January 13, 2014 Washington DC Context: Maternal Mortality and HIV HIV and complications of
More informationDownloaded from:
O Hara, GA; Elliott, AM (2016) HIV and Helminths - Not All Worms Created Equal? Trends in parasitology. ISSN 1471-4922 DOI: https://doi.org/10.1016/j.pt.2016 Downloaded from: http://researchonline.lshtm.ac.uk/3327115/
More informationConference Item (paper)
Eliud Wekesa and Ernestina Coast "Just like a taste of water which is too little to quench the thirst": condom use among people living with HIV/AIDS in Nairobi urban slums Conference Item (paper) Original
More informationGLOBAL HIV STATISTICS
F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were
More informationTo provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.
Module 2 Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Learning Objectives To provide you with the basic concepts of HIV prevention using HIV rapid
More informationBy: Kokeb T. January, 2016.
Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia Region, Ethiopia: retrospective cohort study. By: Kokeb T. January,
More informationHIV Prevention Cascades Stakeholder Consultation Meeting and Workshop 31 July 2 August 2017, Harare, Zimbabwe
HIV Prevention Cascades Stakeholder Consultation Meeting and Workshop 31 July 2 August 2017, Harare, Zimbabwe Report on a consultation and workshop organised by the Manicaland Centre for Public Health
More informationTime to Invest: Building the case for investment in contraception
Time to Invest: Building the case for investment in contraception Improved Gender Equity Index score Increased GDP per capita Foreign aid as a % of government revenue falling Increased girl s primary school
More informationMIGRATION, MINES AND MORES: THE HIV EPIDEMIC IN SOUTHERN AFRICA
MIGRATION, MINES AND MORES: THE HIV EPIDEMIC IN SOUTHERN AFRICA John Hargrove Introduction to the Applications of Mathematics in Biology and Medicine AIMS, Muizenberg 2 July 2012 The colonial map of Africa
More informationHIV Development Assistance and Adult Mortality in Africa: A replication study of Bendavid et al. (2012)
HIV Development Assistance and Adult Mortality in Africa: A replication study of Bendavid et al. (2012) Jiangtao Luo, Ph. D. A replication study proposal submitted to 3ie s Replication Window 3: HIV Prevention
More informationElimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014
Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child
More informationMain global and regional trends
I N T R O D U C T I O N Main global and regional trends Promising developments have been seen in recent years in global efforts to address the AS epidemic, including increased access to effective treatment
More informationPROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS
29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A
More informationHPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission
HPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission TWEET LIVE #HPTN071 DIAL IN NUMBER FOR AUDIO: 1-866-740-1260 BROADCAST AUDIO CODE: 4011527 PLEASE USE THE CHAT
More informationPatterns and risk factors for HIV infection in children in eastern Zimbabwe
International Population Conference 2013 - IUSSP THEME 2 HIV/AIDS and STDs Session 203: Reducing the vulnerability of adolescents and young people to HIV and STIs Patterns and risk factors for HIV infection
More informationDownloaded from:
Hosegood, V; Floyd, S; Marston, M; Hill, C; McGrath, N; Isingo, R; Crampin, A; Zaba, B (2007) The effects of high HIV prevalence on orphanhood and living arrangements of children in Malawi, Tanzania, and
More informationThe proportion of HIV incidence due to unsafe injections, unsafe blood transfusions and mother to child transmission in rural Masaka, Uganda
The proportion of HIV incidence due to unsafe injections, unsafe blood transfusions and mother to child transmission in rural Masaka, Uganda Final report for UNAIDS London School of Hygiene and Tropical
More informationHIV Clinical Management: Antiretroviral Therapy and Drug Resistance
HIV Clinical Management: Antiretroviral Therapy and Drug Resistance Judith S. Currier, MD, MSc Professor of Medicine University of California, Los Angeles Disclosures: Research Grant from Theratechnologies
More informationMeasuring and correcting biased child mortality statistics in countries with generalized epidemics of HIV infection
Timothy B Hallett et al. Biased child mortality statistics owing to mothers' HIV-related deaths Measuring and correcting biased child mortality statistics in countries with generalized epidemics of HIV
More informationCOMBINING DATA SOURCES TO EVALUATE HIV HOUSING PROGRAMS: EXAMPLES
COMBINING DATA SOURCES TO EVALUATE HIV HOUSING PROGRAMS: EXAMPLES FROM NEW YORK CITY HOPWA John Rojas, MPA, Director of Administration and Housing Laura Hollod, MPH, Senior Analyst New York City Department
More informationRush to Judgment Understanding the STI-HIV Trials
Rush to Judgment Understanding the STI-HIV Trials Larry Sawers American University, Washington, DC, USA Eileen Stillwaggon Gettysburg College, Gettysburg, PA, USA 7th IAEN Preconference Washington, DC,
More informationA smart and doable investment
90-90-90 A smart and doable investment As of December 2013 Adults and children living with HIV Adults and children newly infected Adult & child deaths due to AIDS 35.0 million [33.2 million 37.2 million]
More informationTrends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University
Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.
More informationAge-Sex Structure for Selected African countries in the early 2000s
Age-Sex Structure for Selected African countries in the early 2000s Abstract This paper uses data from the recent United Nations population projections to examine the changing age-sex structure in selected
More informationDr. Pascal Nji Atanga MD, MPH, PhD(c) University of Buea/Center for International Health, Ludwig Maximillians University Muenchen, Germany
Retention overtime and reasons for stopping lifelong antiretroviral therapy in a group of Cameroonian pregnant and breastfeeding HIVpositive women initiating "Option B+ in the South West Region Dr. Pascal
More informationA Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia
ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT
More informationThe Contribution of HIV to Mortality in Pregnant and Postpartum Women CLARA ANN DURIE CALVERT
The Contribution of HIV to Mortality in Pregnant and Postpartum Women CLARA ANN DURIE CALVERT Thesis submitted in accordance with the requirements for the degree of Doctor of Philosophy University of London
More information